Magnetic marker to detect primary lesion and sentinel node in breast cancer. The MAGTOTAL randomised controlled trial.

Abstract

Background: Several markers have been developed as an alternative to guidewires for non-palpable breast lesion localisation. The study aim was to compare a magnetic marker (seed) with guidewire (wire) for non-palpable breast lesion localisation in combination with a magnetic SLN tracer.